{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:26:33Z","timestamp":1762424793506,"version":"build-2065373602"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04038-z","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:22:11Z","timestamp":1762424531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RPL29 as a radiotherapy-sensitive prognostic biomarker in multiple myeloma"],"prefix":"10.1186","volume":"23","author":[{"given":"Yihua","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5421-5822","authenticated-orcid":false,"given":"Yanping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"issue":"10272","key":"4038_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","volume":"397","author":"NWCJ van de Donk","year":"2021","unstructured":"van de Donk NWCJ, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397(10272):410\u201327. https:\/\/doi.org\/10.1016\/S0140-6736(21)00135-5.","journal-title":"Lancet"},{"issue":"9","key":"4038_CR2","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/ajh.27422","volume":"99","author":"SV Rajkumar","year":"2024","unstructured":"Rajkumar SV. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2024;99(9):1802\u201324. https:\/\/doi.org\/10.1002\/ajh.27422.","journal-title":"Am J Hematol"},{"issue":"1","key":"4038_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/medsci9010003","volume":"9","author":"SA Padala","year":"2021","unstructured":"Padala SA, Barsouk A, Barsouk A, et al. Epidemiology, staging, and management of multiple myeloma. Med Sci. 2021;9(1):3. https:\/\/doi.org\/10.3390\/medsci9010003.","journal-title":"Med Sci"},{"issue":"6","key":"4038_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.trecan.2016.05.002","volume":"2","author":"S Demaria","year":"2016","unstructured":"Demaria S, Coleman CN, Formenti SC. Radiotherapy: changing the game in immunotherapy. Trends Cancer. 2016;2(6):286\u201394. https:\/\/doi.org\/10.1016\/j.trecan.2016.05.002.","journal-title":"Trends Cancer"},{"issue":"6","key":"4038_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrclinonc.2016.211","volume":"14","author":"RR Weichselbaum","year":"2017","unstructured":"Weichselbaum RR, Liang H, Deng L, Fu YX. Radiotherapy and immunotherapy: a beneficial liaison? Nat Rev Clin Oncol. 2017;14(6):365\u201379. https:\/\/doi.org\/10.1038\/nrclinonc.2016.211.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"4038_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.immuni.2015.03.009","volume":"42","author":"L Surace","year":"2015","unstructured":"Surace L, Lysenko V, Fontana AO, et al. Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response. Immunity. 2015;42(4):767\u201377. https:\/\/doi.org\/10.1016\/j.immuni.2015.03.009.","journal-title":"Immunity"},{"issue":"11","key":"4038_CR7","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1158\/1535-7163.MCT-18-0470","volume":"17","author":"X Tu","year":"2018","unstructured":"Tu X, Kahila MM, Zhou Q, et al. ATR inhibition is a promising radiosensitizing strategy for Triple-Negative breast cancer. Mol Cancer Ther. 2018;17(11):2462\u201372. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-0470.","journal-title":"Mol Cancer Ther"},{"issue":"16","key":"4038_CR8","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1158\/1078-0432.CCR-14-2824","volume":"21","author":"A Filatenkov","year":"2015","unstructured":"Filatenkov A, Baker J, Mueller AM, et al. Ablative tumor radiation can change the tumor immune cell microenvironment to induce durable complete remissions. Clin Cancer Res. 2015;21(16):3727\u201339. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2824.","journal-title":"Clin Cancer Res"},{"issue":"16","key":"4038_CR9","doi-asserted-by":"publisher","first-page":"7700","DOI":"10.7150\/thno.61459","volume":"11","author":"D Sonanini","year":"2021","unstructured":"Sonanini D, Griessinger CM, Sch\u00f6rg BF, et al. Low-dose total body irradiation facilitates antitumoral Th1 immune responses. Theranostics. 2021;11(16):7700\u201314. https:\/\/doi.org\/10.7150\/thno.61459. Published 2021 Jun 16.","journal-title":"Theranostics"},{"key":"4038_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101710","volume":"35","author":"L Gao","year":"2023","unstructured":"Gao L, Zhang A. Low-dose radiotherapy effects the progression of anti-tumor response. Transl Oncol. 2023;35:101710. https:\/\/doi.org\/10.1016\/j.tranon.2023.101710.","journal-title":"Transl Oncol"},{"issue":"6","key":"4038_CR11","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/SLA.0000000000002410","volume":"268","author":"RJ Kelly","year":"2018","unstructured":"Kelly RJ, Zaidi AH, Smith MA, et al. The dynamic and transient immune microenvironment in locally advanced esophageal adenocarcinoma post chemoradiation. Ann Surg. 2018;268(6):992\u20139. https:\/\/doi.org\/10.1097\/SLA.0000000000002410.","journal-title":"Ann Surg"},{"issue":"10","key":"4038_CR12","doi-asserted-by":"publisher","first-page":"e467","DOI":"10.1016\/S2352-3026(16)30108-9","volume":"3","author":"C Agostinelli","year":"2016","unstructured":"Agostinelli C, Gallamini A, Stracqualursi L, et al. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical hodgkin\u2019s lymphoma: a retrospective, European, multicentre cohort study. Lancet Haematol. 2016;3(10):e467\u201379. https:\/\/doi.org\/10.1016\/S2352-3026(16)30108-9.","journal-title":"Lancet Haematol"},{"issue":"2","key":"4038_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41375-019-0590-x","volume":"34","author":"G An","year":"2020","unstructured":"An G, Yan Y, Xu Y, et al. Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myeloma. Leukemia. 2020;34(2):578\u201388. https:\/\/doi.org\/10.1038\/s41375-019-0590-x.","journal-title":"Leukemia"},{"issue":"15","key":"4038_CR14","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1182\/blood-2015-08-665679","volume":"127","author":"B Paiva","year":"2016","unstructured":"Paiva B, Corchete LA, Vidriales MB, et al. Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance. Blood. 2016;127(15):1896\u2013906. https:\/\/doi.org\/10.1182\/blood-2015-08-665679.","journal-title":"Blood"},{"issue":"2","key":"4038_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000371545","volume":"91","author":"S Muro","year":"2015","unstructured":"Muro S, Miyake Y, Kato H, Tsutsumi K, Yamamoto K. Serum anti-60S ribosomal protein L29 antibody as a novel prognostic marker for unresectable pancreatic cancer. Digestion. 2015;91(2):164\u201373. https:\/\/doi.org\/10.1159\/000371545.","journal-title":"Digestion"},{"issue":"1\u20132","key":"4038_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11010-012-1404-x","volume":"370","author":"C Li","year":"2012","unstructured":"Li C, Ge M, Yin Y, Luo M, Chen D. Silencing expression of ribosomal protein L26 and L29 by RNA interfering inhibits proliferation of human pancreatic cancer PANC-1 cells. Mol Cell Biochem. 2012;370(1\u20132):127\u201339. https:\/\/doi.org\/10.1007\/s11010-012-1404-x.","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"4038_CR17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/biot.201300321","volume":"9","author":"C Li","year":"2014","unstructured":"Li C, Chen D, Luo M, Ge M, Zhu J. Knockdown of ribosomal protein L39 by RNA interference inhibits the growth of human pancreatic cancer cells in vitro and in vivo. Biotechnol J. 2014;9(5):652\u201363. https:\/\/doi.org\/10.1002\/biot.201300321.","journal-title":"Biotechnol J"},{"issue":"2","key":"4038_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jcp.20589","volume":"207","author":"JJ Liu","year":"2006","unstructured":"Liu JJ, Huang BH, Zhang J, Carson DD, Hooi SC. Repression of HIP\/RPL29 expression induces differentiation in colon cancer cells. J Cell Physiol. 2006;207(2):287\u201392. https:\/\/doi.org\/10.1002\/jcp.20589.","journal-title":"J Cell Physiol"},{"issue":"4","key":"4038_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.7326\/M23-2540","volume":"177","author":"E Eythorsson","year":"2024","unstructured":"Eythorsson E, Rognvaldsson S, Thorsteinsdottir S, et al. Development of a multivariable model to predict the need for bone marrow sampling in persons with monoclonal gammopathy of undetermined significance: A cohort study nested in a clinical trial. Ann Intern Med. 2024;177(4):449\u201357. https:\/\/doi.org\/10.7326\/M23-2540.","journal-title":"Ann Intern Med"},{"issue":"8","key":"4038_CR20","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1200\/JCO.21.02734","volume":"41","author":"P Sonneveld","year":"2023","unstructured":"Sonneveld P, Chanan-Khan A, Weisel K, et al. Overall survival with Daratumumab, Bortezomib, and dexamethasone in previously treated multiple myeloma (CASTOR): a randomized, open-label, phase III trial. J Clin Oncol. 2023;41(8):1600\u20139. https:\/\/doi.org\/10.1200\/JCO.21.02734.","journal-title":"J Clin Oncol"},{"issue":"18","key":"4038_CR21","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1200\/JCO.2012.47.7901","volume":"31","author":"E Terpos","year":"2013","unstructured":"Terpos E, Morgan G, Dimopoulos MA, et al. International myeloma working group recommendations for the treatment of multiple myeloma-related bone disease. J Clin Oncol. 2013;31(18):2347\u201357. https:\/\/doi.org\/10.1200\/JCO.2012.47.7901.","journal-title":"J Clin Oncol"},{"issue":"3","key":"4038_CR22","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/S1470-2045(20)30559-3","volume":"22","author":"E Terpos","year":"2021","unstructured":"Terpos E, Zamagni E, Lentzsch S, et al. Treatment of multiple myeloma-related bone disease: recommendations from the bone working group of the international myeloma working group. Lancet Oncol. 2021;22(3):e119\u201330. https:\/\/doi.org\/10.1016\/S1470-2045(20)30559-3.","journal-title":"Lancet Oncol"},{"issue":"18","key":"4038_CR23","doi-asserted-by":"publisher","first-page":"4787","DOI":"10.1158\/0008-5472.CAN-19-0530","volume":"79","author":"X Zheng","year":"2019","unstructured":"Zheng X, Cui L, Chen M, Soto LA, Graves EE, Rao J. A near-infrared phosphorescent nanoprobe enables quantitative, longitudinal imaging of tumor hypoxia dynamics during radiotherapy. Cancer Res. 2019;79(18):4787\u201397. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0530.","journal-title":"Cancer Res"},{"issue":"5","key":"4038_CR24","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.7150\/thno.32648","volume":"9","author":"OM Ozpiskin","year":"2019","unstructured":"Ozpiskin OM, Zhang L, Li JJ. Immune targets in the tumor microenvironment treated by radiotherapy. Theranostics. 2019;9(5):1215\u201331. https:\/\/doi.org\/10.7150\/thno.32648. Published 2019 Jan 30.","journal-title":"Theranostics"},{"issue":"4","key":"4038_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00401-011-0869-0","volume":"122","author":"I Casafont","year":"2011","unstructured":"Casafont I, Palanca A, Lafarga V, Berciano MT, Lafarga M. Effect of ionizing radiation in sensory ganglion neurons: organization and dynamics of nuclear compartments of DNA damage\/repair and their relationship with transcription and cell cycle. Acta Neuropathol. 2011;122(4):481\u201393. https:\/\/doi.org\/10.1007\/s00401-011-0869-0.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"4038_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052484","volume":"23","author":"S Shadfar","year":"2022","unstructured":"Shadfar S, Brocardo M, Atkin JD. The complex mechanisms by which neurons die following DNA damage in neurodegenerative diseases. Int J Mol Sci. 2022;23(5):2484. https:\/\/doi.org\/10.3390\/ijms23052484.","journal-title":"Int J Mol Sci"},{"issue":"44","key":"4038_CR27","doi-asserted-by":"publisher","first-page":"71856","DOI":"10.18632\/oncotarget.12379","volume":"7","author":"G Yang","year":"2016","unstructured":"Yang G, Yu D, Li W, et al. Distinct biological effects of low-dose radiation on normal and cancerous human lung cells are mediated by ATM signaling. Oncotarget. 2016;7(44):71856\u201372. https:\/\/doi.org\/10.18632\/oncotarget.12379.","journal-title":"Oncotarget"},{"key":"4038_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2020.106212","volume":"149","author":"K Lumniczky","year":"2021","unstructured":"Lumniczky K, Impens N, Armengol G, et al. Low dose ionizing radiation effects on the immune system. Environ Int. 2021;149:106212. https:\/\/doi.org\/10.1016\/j.envint.2020.106212.","journal-title":"Environ Int"},{"key":"4038_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.aquatox.2013.05.006","volume":"140","author":"JS Rhee","year":"2013","unstructured":"Rhee JS, Kim BM, Kim RO, et al. Co-expression of antioxidant enzymes with expression of p53, DNA repair, and heat shock protein genes in the gamma ray-irradiated hermaphroditic fish kryptolebias marmoratus larvae. Aquat Toxicol. 2013;140:58\u201367. https:\/\/doi.org\/10.1016\/j.aquatox.2013.05.006.","journal-title":"Aquat Toxicol"},{"issue":"2","key":"4038_CR30","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/cncr.26289","volume":"118","author":"J Xiong","year":"2012","unstructured":"Xiong J, Sun WJ, Wang WF, et al. Novel, chimeric, cancer-specific, and radiation-inducible gene promoters for suicide gene therapy of cancer. Cancer. 2012;118(2):536\u201348. https:\/\/doi.org\/10.1002\/cncr.26289.","journal-title":"Cancer"},{"issue":"1","key":"4038_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22989-1","volume":"12","author":"JE Lewis","year":"2021","unstructured":"Lewis JE, Kemp ML. Integration of machine learning and genome-scale metabolic modeling identifies multi-omics biomarkers for radiation resistance. Nat Commun. 2021;12(1):2700. https:\/\/doi.org\/10.1038\/s41467-021-22989-1.","journal-title":"Nat Commun"},{"issue":"3\u20134","key":"4038_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.18632\/oncoscience.298","volume":"3","author":"L Luzhna","year":"2016","unstructured":"Luzhna L, Filkowski J, Kovalchuk O. High and low dose radiation effects on mammary adenocarcinoma cells - an epigenetic connection. Oncoscience. 2016;3(3\u20134):88\u201397. https:\/\/doi.org\/10.18632\/oncoscience.298. Published 2016 Mar 10.","journal-title":"Oncoscience"},{"issue":"1","key":"4038_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.188","volume":"4","author":"S St\u00e5hl","year":"2013","unstructured":"St\u00e5hl S, Kaminskyy VO, Efazat G, et al. Inhibition of Ephrin B3-mediated survival signaling contributes to increased cell death response of non-small cell lung carcinoma cells after combined treatment with ionizing radiation and PKC 412. Cell Death Dis. 2013;4(1):e454. https:\/\/doi.org\/10.1038\/cddis.2012.188.","journal-title":"Cell Death Dis"},{"issue":"6","key":"4038_CR34","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41419-022-04978-4","volume":"13","author":"C Thumser-Henner","year":"2022","unstructured":"Thumser-Henner C, Oeck S, Kalmbach S, et al. Syntaxin 18 regulates the DNA damage response and epithelial-to-mesenchymal transition to promote radiation resistance of lung cancer. Cell Death Dis. 2022;13(6):529. https:\/\/doi.org\/10.1038\/s41419-022-04978-4. Published 2022 Jun 6.","journal-title":"Cell Death Dis"},{"issue":"9","key":"4038_CR35","doi-asserted-by":"publisher","first-page":"e161118","DOI":"10.1172\/jci.insight.161118","volume":"8","author":"S Soleymanjahi","year":"2023","unstructured":"Soleymanjahi S, Blanc V, Molitor EA, et al. RBM47 regulates intestinal injury and tumorigenesis by modifying proliferation, oxidative response, and inflammatory pathways. JCI Insight. 2023;8(9):e161118. https:\/\/doi.org\/10.1172\/jci.insight.161118. Published 2023 May 8.","journal-title":"JCI Insight"},{"key":"4038_CR36","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.3389\/fmicb.2017.02002","volume":"8","author":"C Pacelli","year":"2017","unstructured":"Pacelli C, Selbmann L, Moeller R, Zucconi L, Fujimori A, Onofri S. Cryptoendolithic Antarctic black fungus Cryomyces antarcticus irradiated with accelerated helium ions: survival and metabolic activity, DNA and ultrastructural damage. Front Microbiol. 2017;8:2002. https:\/\/doi.org\/10.3389\/fmicb.2017.02002. (Published 2017 Oct 17).","journal-title":"Front Microbiol"},{"issue":"5","key":"4038_CR37","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/ijc.31297","volume":"143","author":"M Lecavalier-Barsoum","year":"2018","unstructured":"Lecavalier-Barsoum M, Chaudary N, Han K, Koritzinsky M, Hill R, Milosevic M. Targeting the CXCL12\/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer. Int J Cancer. 2018;143(5):1017\u201328. https:\/\/doi.org\/10.1002\/ijc.31297.","journal-title":"Int J Cancer"},{"key":"4038_CR38","doi-asserted-by":"publisher","first-page":"26526","DOI":"10.1038\/srep26526","volume":"6","author":"C Wang","year":"2016","unstructured":"Wang C, Nie H, Li Y, et al. The study of the relation of DNA repair pathway genes SNPs and the sensitivity to radiotherapy and chemotherapy of NSCLC. Sci Rep. 2016;6:26526. https:\/\/doi.org\/10.1038\/srep26526. Published 2016 Jun 1.","journal-title":"Sci Rep"},{"issue":"96","key":"4038_CR39","doi-asserted-by":"publisher","first-page":"36867","DOI":"10.18632\/oncotarget.26409","volume":"9","author":"M Toma","year":"2018","unstructured":"Toma M, Witusik-Perkowska M, Szwed M, et al. Eradication of LIG4-deficient glioblastoma cells by the combination of PARP inhibitor and alkylating agent. Oncotarget. 2018;9(96):36867\u201377. https:\/\/doi.org\/10.18632\/oncotarget.26409. Published 2018 Dec 7.","journal-title":"Oncotarget"},{"issue":"4","key":"4038_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/sj.cr.7290230","volume":"14","author":"MH Jeong","year":"2004","unstructured":"Jeong MH, Jin YH, Kang EY, et al. The modulation of radiation-induced cell death by genistein in K562 cells: activation of thymidine kinase 1. Cell Res. 2004;14(4):295\u2013302. https:\/\/doi.org\/10.1038\/sj.cr.7290230.","journal-title":"Cell Res"},{"issue":"11","key":"4038_CR41","doi-asserted-by":"publisher","first-page":"7514","DOI":"10.4049\/jimmunol.0900063","volume":"183","author":"C Sina","year":"2009","unstructured":"Sina C, Gavrilova O, F\u00f6rster M, et al. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol. 2009;183(11):7514\u201322. https:\/\/doi.org\/10.4049\/jimmunol.0900063.","journal-title":"J Immunol"},{"issue":"16","key":"4038_CR42","doi-asserted-by":"publisher","first-page":"8250","DOI":"10.1158\/0008-5472.CAN-06-1416","volume":"66","author":"H Suttmann","year":"2006","unstructured":"Suttmann H, Riemensberger J, Bentien G, et al. Neutrophil granulocytes are required for effective Bacillus Calmette-Gu\u00e9rin immunotherapy of bladder cancer and orchestrate local immune responses. Cancer Res. 2006;66(16):8250\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-1416.","journal-title":"Cancer Res"},{"issue":"2","key":"4038_CR43","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2015.04.016","volume":"368","author":"N Hekim","year":"2015","unstructured":"Hekim N, Cetin Z, Nikitaki Z, Cort A, Saygili EI. Radiation triggering immune response and inflammation. Cancer Lett. 2015;368(2):156\u201363. https:\/\/doi.org\/10.1016\/j.canlet.2015.04.016.","journal-title":"Cancer Lett"},{"issue":"3","key":"4038_CR44","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/JLB.3MR0717-292R","volume":"103","author":"MR Galdiero","year":"2018","unstructured":"Galdiero MR, Varricchi G, Loffredo S, Mantovani A, Marone G. Roles of neutrophils in cancer growth and progression. J Leukoc Biol. 2018;103(3):457\u201364. https:\/\/doi.org\/10.1002\/JLB.3MR0717-292R.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"4038_CR45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41423-020-00602-7","volume":"18","author":"K Onomoto","year":"2021","unstructured":"Onomoto K, Onoguchi K, Yoneyama M. Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors. Cell Mol Immunol. 2021;18(3):539\u201355. https:\/\/doi.org\/10.1038\/s41423-020-00602-7.","journal-title":"Cell Mol Immunol"},{"key":"4038_CR46","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cytogfr.2020.04.003","volume":"55","author":"J Lokau","year":"2020","unstructured":"Lokau J, Garbers C. Biological functions and therapeutic opportunities of soluble cytokine receptors. Cytokine Growth Factor Rev. 2020;55:94\u2013108. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.04.003.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"4038_CR47","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.7150\/thno.96944","volume":"14","author":"SC Kleinendorst","year":"2024","unstructured":"Kleinendorst SC, Oosterwijk E, Molkenboer-Kuenen J, et al. Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma. Theranostics. 2024;14(9):3693\u2013707. https:\/\/doi.org\/10.7150\/thno.96944. (Published 2024 Jun 11).","journal-title":"Theranostics"},{"issue":"2","key":"4038_CR48","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.canlet.2015.04.010","volume":"368","author":"B Frey","year":"2015","unstructured":"Frey B, Hehlgans S, R\u00f6del F, Gaipl US. Modulation of inflammation by low and high doses of ionizing radiation: implications for benign and malign diseases. Cancer Lett. 2015;368(2):230\u20137. https:\/\/doi.org\/10.1016\/j.canlet.2015.04.010.","journal-title":"Cancer Lett"},{"issue":"11","key":"4038_CR49","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1158\/1078-0432.CCR-10-3346","volume":"17","author":"A Andersson","year":"2011","unstructured":"Andersson A, Srivastava MK, Harris-White M, et al. Role of CXCR3 ligands in IL-7\/IL-7R alpha-Fc-mediated antitumor activity in lung cancer. Clin Cancer Res. 2011;17(11):3660\u201372. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-3346.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4038_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12992","volume":"50","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wu Q, Zhang X, et al. NLRP3 promotes radiation-induced brain injury by regulating microglial pyroptosis. Neuropathol Appl Neurobiol. 2024;50(3):e12992. https:\/\/doi.org\/10.1111\/nan.12992.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"4038_CR51","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1089\/ars.2017.7305","volume":"27","author":"H Huang","year":"2017","unstructured":"Huang H, Du W, Brekken RA. Extracellular matrix induction of intracellular reactive oxygen species. Antioxid Redox Signal. 2017;27(12):774\u201384. https:\/\/doi.org\/10.1089\/ars.2017.7305.","journal-title":"Antioxid Redox Signal"},{"key":"4038_CR52","doi-asserted-by":"publisher","first-page":"742370","DOI":"10.3389\/fimmu.2021.742370","volume":"12","author":"A Afriyie-Asante","year":"2021","unstructured":"Afriyie-Asante A, Dabla A, Dagenais A, Berton S, Smyth R, Sun J. Mycobacterium tuberculosis exploits focal adhesion kinase to induce necrotic cell death and inhibit reactive oxygen species production. Front Immunol. 2021;12:742370. https:\/\/doi.org\/10.3389\/fimmu.2021.742370. (Published 2021 Oct 20).","journal-title":"Front Immunol"},{"issue":"2","key":"4038_CR53","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ultrasmedbio.2016.09.020","volume":"43","author":"R Cirincione","year":"2017","unstructured":"Cirincione R, Di Maggio FM, Forte GI, et al. High-intensity focused ultrasound- and radiation therapy-induced immuno-modulation: comparison and potential opportunities. Ultrasound Med Biol. 2017;43(2):398\u2013411. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2016.09.020.","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"4038_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12964-019-0362-2","volume":"17","author":"Z Wang","year":"2019","unstructured":"Wang Z, Tang Y, Tan Y, Wei Q, Yu W. Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities. Cell Commun Signal. 2019;17(1):47. https:\/\/doi.org\/10.1186\/s12964-019-0362-2. Published 2019 May 17.","journal-title":"Cell Commun Signal"},{"issue":"8","key":"4038_CR55","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1080\/15548627.2017.1332565","volume":"13","author":"SJ Chung","year":"2017","unstructured":"Chung SJ, Nagaraju GP, Nagalingam A, et al. ADIPOQ\/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11\/LKB1-mediated activation of the AMPK-ULK1 axis. Autophagy. 2017;13(8):1386\u2013403. https:\/\/doi.org\/10.1080\/15548627.2017.1332565.","journal-title":"Autophagy"},{"key":"4038_CR56","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cytogfr.2018.01.004","volume":"39","author":"AA Ghadge","year":"2018","unstructured":"Ghadge AA, Khaire AA, Kuvalekar AA, Adiponectin. A potential therapeutic target for metabolic syndrome. Cytokine Growth Factor Rev. 2018;39:151\u20138. https:\/\/doi.org\/10.1016\/j.cytogfr.2018.01.004.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"4038_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13004","volume":"21","author":"S And\u00f2","year":"2020","unstructured":"And\u00f2 S, Naimo GD, Gelsomino L, Catalano S, Mauro L. Novel insights into adiponectin action in breast cancer: evidence of its mechanistic effects mediated by ER\u03b1 expression. Obes Rev. 2020;21(5):e13004. https:\/\/doi.org\/10.1111\/obr.13004.","journal-title":"Obes Rev"},{"key":"4038_CR58","doi-asserted-by":"crossref","unstructured":"Solimando AG, Eleonora Malerba. Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche. Front Oncol. 2022 Sep 21:12:973836.doi: 10.3389\/fonc.2022.973836. eCollection,. 2022.","DOI":"10.3389\/fonc.2022.973836"},{"key":"4038_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.628907","volume":"12","author":"H Joshi","year":"2021","unstructured":"Joshi H, Vastrad B, Joshi N, Vastrad C, Tengli A, Kotturshetti I. Identification of key pathways and genes in obesity using bioinformatics analysis and molecular docking studies. Front Endocrinol (Lausanne). 2021;12:628907. https:\/\/doi.org\/10.3389\/fendo.2021.628907.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4038_CR60","doi-asserted-by":"publisher","unstructured":"Khalid Z, Huan M, Sohail Raza M et al. Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics [published correction appears in Front Microbiol. 2022;13:1059437. doi: 10.3389\/fmicb.2022.1059437.]. Front Microbiol. 2022;13:901848. Published 2022 Aug 2. https:\/\/doi.org\/10.3389\/fmicb.2022.901848.","DOI":"10.3389\/fmicb.2022.901848."},{"issue":"9","key":"4038_CR61","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1166\/jbn.2017.2410","volume":"13","author":"S Wenzhi","year":"2017","unstructured":"Wenzhi S, Dezhou W, Ming R, et al. Growth inhibition effect and validation of stable expressed reference genes for near-infrared photothermal therapy mediated by gold nanoflower particles on human tongue carcinoma Tca-8113 cells. J Biomed Nanotechnol. 2017;13(9):1158\u201367. https:\/\/doi.org\/10.1166\/jbn.2017.2410.","journal-title":"J Biomed Nanotechnol"},{"issue":"5","key":"4038_CR62","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4111\/icu.2019.60.5.359","volume":"60","author":"H Li","year":"2019","unstructured":"Li H, Zhang Z, Peng J, et al. Treatment with low-energy shock wave alleviates pain in an animal model of uroplakin 3A-induced autoimmune interstitial cystitis\/painful bladder syndrome. Investig Clin Urol. 2019;60(5):359\u201366. https:\/\/doi.org\/10.4111\/icu.2019.60.5.359.","journal-title":"Investig Clin Urol"},{"issue":"4","key":"4038_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0047-8","volume":"50","author":"WY Chen","year":"2018","unstructured":"Chen WY, Yang JL, Wu YH, et al. IL-33\/ST2 axis mediates hyperplasia of intrarenal urothelium in obstructive renal injury. Exp Mol Med. 2018;50(4):1\u201311. https:\/\/doi.org\/10.1038\/s12276-018-0047-8. Published 2018 Apr 20.","journal-title":"Exp Mol Med"},{"issue":"9","key":"4038_CR64","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1111\/cas.14118","volume":"110","author":"M Elbadawy","year":"2019","unstructured":"Elbadawy M, Usui T, Mori T, et al. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture. Cancer Sci. 2019;110(9):2806\u201321. https:\/\/doi.org\/10.1111\/cas.14118.","journal-title":"Cancer Sci"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04038-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04038-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04038-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:22:13Z","timestamp":1762424533000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-04038-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4038"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04038-z","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Ethics Committee of Second Hospital of Shanxi Medical University (Approval Number: KY2025006).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"418"}}